Prostate Cancer News and Research

Latest Prostate Cancer News and Research

UH receives federal grants to pursue projects related to prostate cancer, diabetes and obesity

Researchers at the University of Houston (UH) have been awarded more than $862,000 in federal grants to pursue projects related to prostate cancer, diabetes and obesity. The U.S. Department of Defense (DOD) and National Institutes of Health (NIH) will fund two new prostate cancer projects, while a third NIH grant will support diabetes and obesity research in the UH Center for Nuclear Receptors and Cell Signaling (CNRCS).

28 Jun 2012

Second potential immune checkpoint target for cancer immunotherapy announced by Compugen

Compugen Ltd. (NASDAQ: CGEN) announced today results demonstrating the therapeutic potential of CGEN-15022, a Compugen-discovered B7/CD28-like membrane protein, as an immune checkpoint target for treatment of multiple cancers.

27 Jun 2012

Combination of radiation therapies effectively treat prostate cancer, lower chances of recurrence

A recent Phase I/II clinical trial has shown that a new combination of radiation therapies developed at Virginia Commonwealth University Massey Cancer Center escalates radiation doses to safely and effectively treat prostate cancer and lower the risk of recurrence with minimal radiation exposure to nearby healthy tissue and organs.

27 Jun 2012

Astellas submits enzalutamide MAA with EMA for treatment of CRPC

Today, Astellas Pharma Inc. announces the submission of a European marketing authorisation application to the European Medicines Agency (EMA) for enzalutamide for the treatment of men with metastatic castration-resistant prostate cancer who have been previously treated with docetaxel-based chemotherapy.

27 Jun 2012

Biological filter to remove estrogens from waste water and drinking water

A biological filter to remove estrogens from waste water and drinking water. The 15 Bielefeld students submitting this project to the 'international Genetically Engineered Machine competition' (iGEM) at the Massachusetts Institute of Technology (MIT) in Boston, USA are setting their sights high.

26 Jun 2012

Beckman Coulter announces PMA from FDA for Prostate Health Index

Beckman Coulter, Inc., the leader in prostate cancer diagnostics, announces Premarket Approval (PMA) from the U.S. Food and Drug Administration (FDA) for the Prostate Health Index (phi), a simple, non-invasive blood test that is 2.5-times more specific in detecting prostate cancer than PSA (prostate-specific antigen) in patients with PSA values in the 4-10 ng/mL range and is proven to reduce the number of prostate biopsies.

From Beckman Coulter Diagnostics 26 Jun 2012

Disorganized cancers more difficult to treat and consistently result in lower survival rates

Medical researchers at the University of Alberta reviewed test results from thousands of patients with various types of cancer and discovered that "disorganized" cancers were more difficult to treat and consistently resulted in lower survival rates.

23 Jun 2012

Viewpoints: Berwick says health law puts system 'on the right track;' Mandate's effect overstated; Questions about Axelrod's ties

Obamacare is helping our nation achieve health care that is excellent, accessible to all and affordable. In the 17 months that I led the Centers for Medicare and Medicaid Services (CMS), I saw how this law is helping tens of millions of families and is finally putting our health-care system on the right track.

23 Jun 2012

Faulty conclusions due to contamination, misidentification and redundancy in widely available cell lines

Modern cancer therapies start in cells - researchers compare cancer samples to healthy cells to discover how cancer is genetically different, and use cell lines to test promising new drugs. However, a University of Colorado Cancer Center study published this week in the journal Gynecologic Oncology shows that due to a high rate of contamination, misidentification and redundancy in widely available cell lines, researchers may be drawing faulty conclusions.

22 Jun 2012

Review describes new classes of drugs that target androgens in novel ways

Prostate cancer cells require androgens including testosterone to grow. A recent review in the British Journal of Urology International describes new classes of drugs that target androgens in novel ways, providing alternatives to the traditional methods that frequently carry high side effects.

21 Jun 2012

New robotic device can improve detection of breast cancer

One in eight women in the United States will develop breast cancer over the course of her lifetime. Lorraine G. Olson, professor of mechanical engineering at the Rose-Hulman Institute of Technology in Terre Haute, Indiana, was diagnosed in 2005 at the age of 45. Fortunately, her breast cancer was caught early from a routine mammogram, but like many women, she was prodded by her physician to do the exam.

21 Jun 2012

Six novel genetic associations for early onset male pattern baldness

Using data from its unique online research platform, 23andMe, a leading personal genetics company, has contributed to the finding of six novel genetic associations for early onset male pattern baldness (androgenetic alopecia) in a genome-wide association study now published online in the journal PLoS Genetics.

20 Jun 2012

Agility MLC's new design provides better dose sculpting capabilities

Requiring only a quick upgrade to their existing Elekta Synergy linear accelerator, physicians at SALK and Paracelsus Medical University began using the new Agility 160-leaf multileaf collimator (MLC), treating 33 patients on its first day. In its first month of Agility use, the center now treats 50 patients per day, comprising about 700 individual treatment sessions that have benefited from this breakthrough in cancer care.

From Elekta 18 Jun 2012

Spectros introduces OnCall wireless remote access to view real-time patient results

Spectros Corporation announces the successful launch of OnCall wireless remote access for viewing real-time patient results on T-Stat white light tissue oximeters.

18 Jun 2012

Is curry good for you?

There have been several news stories over the years reporting that curry may be good for us. Most of them refer to a chemical in curry, known as curcumin.

18 Jun 2012

100BMOA releases official statement on prostate cancer

100 Black Men of America, Inc., Chairman Albert E. Dotson, Jr., the Board of Directors and the Executive Committee of 100 Black Men of America, Inc. release an official statement on prostate cancer, in an effort to save lives of countless men who are at the highest risk of developing prostate cancer.

18 Jun 2012

Top five prostate wellness tips

David Samadi, MD, Vice-Chair of Urology at Mount Sinai School of Medicine, knows that many men put off caring for their health, even when they have a family. But just a loving nudge from his family can help keep Dad on track for long-term prostate health, prostate cancer prevention, and prostate cancer awareness.

15 Jun 2012

Study: Quirky fruit fly gene can help develop new weapons against cancer

Loyola University Chicago researchers are taking advantage of a quirk in the evolution of fruit fly genes to help develop new weapons against cancer.

15 Jun 2012

Advaxis announces publication of preclinical research with ADXS-PSA

Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced the publication of preclinical research with ADXS-PSA (ADXS31-142), Advaxis' Lm-LLO immunotherapy targeting the PSA antigen associated with prostate cancer.

14 Jun 2012

Mayo Clinic urologists recommend personalized approach for prostate cancer screening

There is a lot of conflicting advice about prostate cancer screening. A recent U.S. Preventative Services Task Force recommendation against prostate-specific antigen testing, regardless of age, has added to men's confusion about how to protect themselves from a cancer that hits roughly 240,000 new patients every year and claims 28,000 lives.

14 Jun 2012

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

UH receives federal grants to pursue projects related to prostate cancer, diabetes and obesity

Second potential immune checkpoint target for cancer immunotherapy announced by Compugen

Combination of radiation therapies effectively treat prostate cancer, lower chances of recurrence

Astellas submits enzalutamide MAA with EMA for treatment of CRPC

Biological filter to remove estrogens from waste water and drinking water

Beckman Coulter announces PMA from FDA for Prostate Health Index

Disorganized cancers more difficult to treat and consistently result in lower survival rates

Viewpoints: Berwick says health law puts system 'on the right track;' Mandate's effect overstated; Questions about Axelrod's ties

Faulty conclusions due to contamination, misidentification and redundancy in widely available cell lines

Review describes new classes of drugs that target androgens in novel ways

New robotic device can improve detection of breast cancer

Six novel genetic associations for early onset male pattern baldness

Agility MLC's new design provides better dose sculpting capabilities

Spectros introduces OnCall wireless remote access to view real-time patient results

Is curry good for you?

100BMOA releases official statement on prostate cancer

Top five prostate wellness tips

Study: Quirky fruit fly gene can help develop new weapons against cancer

Advaxis announces publication of preclinical research with ADXS-PSA

Mayo Clinic urologists recommend personalized approach for prostate cancer screening

What to know about prostate cancer eBook

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

What to know about prostate cancer eBook

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Newsletters you may be interested in